| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Defects, Congenital | 68 | 2023 | 4546 | 2.640 |
Why?
|
| Heart Septal Defects, Ventricular | 33 | 2023 | 485 | 2.170 |
Why?
|
| Transposition of Great Vessels | 33 | 2023 | 582 | 2.080 |
Why?
|
| Echocardiography | 99 | 2019 | 5098 | 1.820 |
Why?
|
| Mitral Valve | 17 | 2022 | 1483 | 1.340 |
Why?
|
| Coronary Vessel Anomalies | 14 | 2016 | 312 | 1.150 |
Why?
|
| Pulmonary Artery | 23 | 2021 | 1909 | 1.080 |
Why?
|
| Mitral Valve Stenosis | 6 | 2022 | 375 | 1.040 |
Why?
|
| Heart Ventricles | 38 | 2021 | 3797 | 1.030 |
Why?
|
| Cardiac Surgical Procedures | 20 | 2017 | 3517 | 0.860 |
Why?
|
| Aortic Valve | 15 | 2022 | 1900 | 0.850 |
Why?
|
| Myocardium | 13 | 2023 | 4779 | 0.840 |
Why?
|
| Pericardium | 6 | 2022 | 665 | 0.770 |
Why?
|
| Echocardiography, Doppler | 22 | 2013 | 934 | 0.770 |
Why?
|
| Aortic Stenosis, Subvalvular | 1 | 2020 | 12 | 0.760 |
Why?
|
| Ventricular Function, Right | 4 | 2020 | 591 | 0.730 |
Why?
|
| Bioprosthesis | 4 | 2023 | 596 | 0.720 |
Why?
|
| Myofibrils | 1 | 2020 | 146 | 0.710 |
Why?
|
| Autopsy | 6 | 2017 | 1003 | 0.700 |
Why?
|
| Nuclear Physics | 6 | 2014 | 79 | 0.690 |
Why?
|
| Tetralogy of Fallot | 12 | 2017 | 621 | 0.670 |
Why?
|
| Heart Valve Prosthesis | 6 | 2023 | 1479 | 0.650 |
Why?
|
| Magnetic Resonance Imaging, Cine | 2 | 2016 | 964 | 0.650 |
Why?
|
| Ventricular Dysfunction | 2 | 2018 | 143 | 0.640 |
Why?
|
| Pulmonary Veins | 9 | 2017 | 759 | 0.640 |
Why?
|
| Aortic Valve Stenosis | 16 | 2021 | 1930 | 0.630 |
Why?
|
| Femoral Vein | 1 | 2018 | 159 | 0.620 |
Why?
|
| Coronary Vessels | 12 | 2016 | 3095 | 0.600 |
Why?
|
| Ultrasonography, Prenatal | 10 | 2019 | 1689 | 0.580 |
Why?
|
| Ventricular Dysfunction, Right | 2 | 2020 | 577 | 0.580 |
Why?
|
| Pulmonary Valve | 13 | 2015 | 437 | 0.570 |
Why?
|
| Infant | 120 | 2023 | 34923 | 0.570 |
Why?
|
| Myocardial Contraction | 24 | 2013 | 1584 | 0.570 |
Why?
|
| Aorta | 16 | 2021 | 2047 | 0.560 |
Why?
|
| Norwood Procedures | 1 | 2018 | 178 | 0.560 |
Why?
|
| Ebstein Anomaly | 4 | 2023 | 97 | 0.560 |
Why?
|
| Calcinosis | 5 | 2023 | 1492 | 0.560 |
Why?
|
| Hypoplastic Left Heart Syndrome | 2 | 2018 | 564 | 0.540 |
Why?
|
| Pulmonary Circulation | 4 | 2016 | 740 | 0.530 |
Why?
|
| Heart Aneurysm | 2 | 2012 | 120 | 0.530 |
Why?
|
| Saphenous Vein | 1 | 2018 | 527 | 0.530 |
Why?
|
| Prosthesis Failure | 3 | 2017 | 1203 | 0.520 |
Why?
|
| Cardiomyopathies | 6 | 2022 | 1910 | 0.520 |
Why?
|
| Aortic Valve Insufficiency | 10 | 2023 | 576 | 0.510 |
Why?
|
| Cardiovascular Abnormalities | 2 | 2019 | 144 | 0.490 |
Why?
|
| Fontan Procedure | 6 | 2017 | 767 | 0.480 |
Why?
|
| Heart Valve Prosthesis Implantation | 6 | 2022 | 1515 | 0.480 |
Why?
|
| Aortic Coarctation | 7 | 2001 | 275 | 0.470 |
Why?
|
| Elementary Particles | 4 | 2014 | 55 | 0.470 |
Why?
|
| Abnormalities, Multiple | 9 | 2013 | 1405 | 0.470 |
Why?
|
| Infant, Newborn | 85 | 2018 | 25470 | 0.460 |
Why?
|
| Fetal Diseases | 10 | 2019 | 903 | 0.440 |
Why?
|
| Fetal Heart | 6 | 2019 | 276 | 0.420 |
Why?
|
| Device Removal | 1 | 2017 | 648 | 0.420 |
Why?
|
| Mitral Valve Insufficiency | 4 | 2022 | 1408 | 0.420 |
Why?
|
| Pulmonary Atresia | 2 | 2008 | 159 | 0.410 |
Why?
|
| Palliative Care | 8 | 2018 | 3461 | 0.400 |
Why?
|
| Vascular Malformations | 1 | 2016 | 442 | 0.400 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2020 | 1257 | 0.390 |
Why?
|
| Ventricular Outflow Obstruction | 6 | 1998 | 271 | 0.390 |
Why?
|
| Child, Preschool | 79 | 2020 | 40801 | 0.380 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 2 | 2020 | 2731 | 0.370 |
Why?
|
| Imaging, Three-Dimensional | 4 | 2021 | 4025 | 0.370 |
Why?
|
| Cardiology | 5 | 2016 | 1654 | 0.360 |
Why?
|
| Extracellular Matrix | 2 | 2014 | 1734 | 0.360 |
Why?
|
| Aorta, Thoracic | 10 | 2023 | 1078 | 0.350 |
Why?
|
| Coronary Angiography | 5 | 2015 | 4556 | 0.350 |
Why?
|
| Drugs, Investigational | 2 | 2001 | 215 | 0.340 |
Why?
|
| Terminology as Topic | 3 | 2021 | 1548 | 0.330 |
Why?
|
| Arrhythmias, Cardiac | 6 | 2023 | 2263 | 0.330 |
Why?
|
| Tricuspid Valve Insufficiency | 6 | 2008 | 345 | 0.320 |
Why?
|
| Tricuspid Valve | 14 | 2023 | 399 | 0.320 |
Why?
|
| Ventricular Function, Left | 18 | 2010 | 3620 | 0.320 |
Why?
|
| Humans | 239 | 2023 | 739219 | 0.320 |
Why?
|
| Prenatal Diagnosis | 7 | 2019 | 1227 | 0.310 |
Why?
|
| Child | 91 | 2021 | 77029 | 0.300 |
Why?
|
| International Classification of Diseases | 3 | 2021 | 867 | 0.300 |
Why?
|
| Heart | 17 | 2023 | 4448 | 0.290 |
Why?
|
| Models, Theoretical | 6 | 2014 | 3605 | 0.290 |
Why?
|
| Sinus of Valsalva | 2 | 2023 | 58 | 0.290 |
Why?
|
| Heart Septal Defects, Atrial | 11 | 2002 | 475 | 0.280 |
Why?
|
| Intestinal Mucosa | 2 | 2014 | 3036 | 0.280 |
Why?
|
| Ultrasonography, Doppler | 3 | 2022 | 460 | 0.280 |
Why?
|
| Perindopril | 1 | 2005 | 12 | 0.270 |
Why?
|
| Heart Valve Diseases | 4 | 2020 | 1058 | 0.260 |
Why?
|
| Echocardiography, Three-Dimensional | 5 | 2008 | 591 | 0.260 |
Why?
|
| Heart Septal Defects | 7 | 2017 | 192 | 0.260 |
Why?
|
| Ductus Arteriosus, Patent | 4 | 2002 | 209 | 0.260 |
Why?
|
| Aortic Diseases | 2 | 2021 | 734 | 0.260 |
Why?
|
| Vasomotor System | 1 | 2005 | 210 | 0.250 |
Why?
|
| Drug Approval | 2 | 2001 | 742 | 0.250 |
Why?
|
| Pediatrics | 8 | 2018 | 3454 | 0.250 |
Why?
|
| Ventricular Dysfunction, Left | 5 | 2005 | 2043 | 0.240 |
Why?
|
| Atrioventricular Node | 2 | 2020 | 182 | 0.240 |
Why?
|
| Pregnancy Complications, Cardiovascular | 1 | 2008 | 509 | 0.230 |
Why?
|
| Stroke Volume | 12 | 2005 | 4941 | 0.230 |
Why?
|
| Elementary Particle Interactions | 2 | 2013 | 19 | 0.230 |
Why?
|
| Myocardial Ischemia | 2 | 2013 | 2145 | 0.230 |
Why?
|
| Pulmonary Valve Stenosis | 5 | 2000 | 183 | 0.230 |
Why?
|
| Aneurysm, False | 2 | 2017 | 275 | 0.230 |
Why?
|
| Coronary Sinus | 1 | 2023 | 87 | 0.220 |
Why?
|
| Clinical Trials as Topic | 5 | 2001 | 7897 | 0.220 |
Why?
|
| Retrospective Studies | 43 | 2023 | 76632 | 0.220 |
Why?
|
| Tachycardia, Ventricular | 2 | 2023 | 1271 | 0.220 |
Why?
|
| Heart Failure | 5 | 2022 | 10793 | 0.210 |
Why?
|
| Muscular Dystrophy, Duchenne | 1 | 2005 | 255 | 0.210 |
Why?
|
| Female | 101 | 2023 | 378808 | 0.210 |
Why?
|
| Adolescent | 57 | 2020 | 85409 | 0.210 |
Why?
|
| Device Approval | 2 | 2000 | 165 | 0.200 |
Why?
|
| Cardiac Volume | 4 | 2012 | 210 | 0.200 |
Why?
|
| Formaldehyde | 1 | 2023 | 354 | 0.200 |
Why?
|
| Prostheses and Implants | 5 | 2002 | 1383 | 0.190 |
Why?
|
| Human Experimentation | 1 | 2001 | 127 | 0.190 |
Why?
|
| Male | 81 | 2023 | 348967 | 0.190 |
Why?
|
| Cardiovascular Surgical Procedures | 2 | 2015 | 194 | 0.190 |
Why?
|
| Venae Cavae | 3 | 2017 | 41 | 0.180 |
Why?
|
| Aortic Arch Syndromes | 1 | 2019 | 19 | 0.180 |
Why?
|
| Foreign-Body Reaction | 2 | 2017 | 157 | 0.170 |
Why?
|
| Isomerism | 2 | 2018 | 201 | 0.170 |
Why?
|
| Accessory Atrioventricular Bundle | 1 | 2020 | 56 | 0.170 |
Why?
|
| Echocardiography, Transesophageal | 10 | 2003 | 1128 | 0.170 |
Why?
|
| Blood Vessel Prosthesis Implantation | 2 | 2017 | 1381 | 0.170 |
Why?
|
| Blood Flow Velocity | 6 | 2004 | 1436 | 0.170 |
Why?
|
| Aortic Aneurysm | 1 | 2023 | 643 | 0.160 |
Why?
|
| Choristoma | 1 | 2020 | 213 | 0.160 |
Why?
|
| Endpoint Determination | 1 | 2001 | 598 | 0.160 |
Why?
|
| Mucocutaneous Lymph Node Syndrome | 4 | 2010 | 548 | 0.160 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2005 | 1510 | 0.160 |
Why?
|
| Aspirin | 4 | 2008 | 3268 | 0.150 |
Why?
|
| Ossification, Heterotopic | 1 | 2020 | 238 | 0.150 |
Why?
|
| Pacemaker, Artificial | 1 | 2023 | 813 | 0.150 |
Why?
|
| Postoperative Complications | 18 | 2016 | 15191 | 0.150 |
Why?
|
| Child Welfare | 4 | 2001 | 520 | 0.150 |
Why?
|
| Mesons | 2 | 2014 | 33 | 0.150 |
Why?
|
| Atrial Septum | 1 | 2017 | 59 | 0.140 |
Why?
|
| Monitoring, Intraoperative | 6 | 2006 | 954 | 0.140 |
Why?
|
| Predictive Value of Tests | 7 | 2021 | 15035 | 0.140 |
Why?
|
| Cartilage | 1 | 2020 | 820 | 0.140 |
Why?
|
| Tissue Transplantation | 1 | 2017 | 130 | 0.140 |
Why?
|
| Pregnancy | 21 | 2019 | 29003 | 0.140 |
Why?
|
| Truncus Arteriosus, Persistent | 2 | 1995 | 63 | 0.140 |
Why?
|
| Heart Valves | 5 | 2023 | 291 | 0.140 |
Why?
|
| Troponin I | 1 | 2020 | 616 | 0.140 |
Why?
|
| Heart Neoplasms | 1 | 2019 | 374 | 0.130 |
Why?
|
| Troponin T | 1 | 2020 | 749 | 0.130 |
Why?
|
| Swine | 5 | 2022 | 5893 | 0.130 |
Why?
|
| Cardiovascular Diseases | 6 | 2009 | 15069 | 0.130 |
Why?
|
| Follow-Up Studies | 30 | 2023 | 38941 | 0.130 |
Why?
|
| Arteries | 1 | 2020 | 1115 | 0.130 |
Why?
|
| Coronary Artery Disease | 1 | 2015 | 6410 | 0.130 |
Why?
|
| Informed Consent | 1 | 2001 | 988 | 0.130 |
Why?
|
| Consensus | 5 | 2021 | 2912 | 0.130 |
Why?
|
| Cardiac Valve Annuloplasty | 1 | 2015 | 50 | 0.120 |
Why?
|
| Young Adult | 14 | 2023 | 56252 | 0.120 |
Why?
|
| Prognosis | 16 | 2023 | 28901 | 0.120 |
Why?
|
| Forensic Medicine | 1 | 2014 | 64 | 0.120 |
Why?
|
| Tissue Fixation | 1 | 2015 | 241 | 0.120 |
Why?
|
| Adult | 57 | 2023 | 213375 | 0.120 |
Why?
|
| Cardiopulmonary Bypass | 3 | 2006 | 1064 | 0.120 |
Why?
|
| Neutrons | 1 | 2014 | 76 | 0.120 |
Why?
|
| Time Factors | 15 | 2017 | 40040 | 0.120 |
Why?
|
| Defibrillators, Implantable | 1 | 2023 | 1441 | 0.120 |
Why?
|
| Fellowships and Scholarships | 2 | 2016 | 1058 | 0.120 |
Why?
|
| Foreign-Body Migration | 1 | 1995 | 222 | 0.110 |
Why?
|
| DiGeorge Syndrome | 1 | 1995 | 177 | 0.110 |
Why?
|
| Echocardiography, Doppler, Color | 2 | 2015 | 364 | 0.110 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2000 | 1331 | 0.110 |
Why?
|
| United States Food and Drug Administration | 4 | 2002 | 1584 | 0.110 |
Why?
|
| Patient Selection | 3 | 2002 | 4211 | 0.110 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2019 | 20038 | 0.110 |
Why?
|
| Bone Diseases, Developmental | 1 | 2013 | 130 | 0.110 |
Why?
|
| Limb Deformities, Congenital | 1 | 2013 | 136 | 0.110 |
Why?
|
| Treatment Outcome | 22 | 2023 | 62691 | 0.110 |
Why?
|
| Hemodynamics | 14 | 2003 | 4196 | 0.110 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2018 | 2634 | 0.100 |
Why?
|
| Watchful Waiting | 1 | 2016 | 489 | 0.100 |
Why?
|
| ADAM Proteins | 1 | 2013 | 242 | 0.100 |
Why?
|
| Cardiac Output | 5 | 1996 | 857 | 0.100 |
Why?
|
| Fatal Outcome | 1 | 2016 | 1850 | 0.100 |
Why?
|
| Systematized Nomenclature of Medicine | 2 | 2021 | 36 | 0.100 |
Why?
|
| Age Factors | 9 | 2020 | 18347 | 0.100 |
Why?
|
| Receptors, Complement | 2 | 2004 | 255 | 0.100 |
Why?
|
| Anastomosis, Surgical | 3 | 1994 | 983 | 0.100 |
Why?
|
| Ventricular Pressure | 3 | 2004 | 199 | 0.100 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2019 | 35274 | 0.100 |
Why?
|
| Histiocytosis, Langerhans-Cell | 1 | 2013 | 172 | 0.100 |
Why?
|
| Prosthesis Design | 1 | 2017 | 2110 | 0.090 |
Why?
|
| Myocytes, Cardiac | 1 | 2019 | 1626 | 0.090 |
Why?
|
| Placenta Diseases | 1 | 2013 | 194 | 0.090 |
Why?
|
| Heart Atria | 8 | 2012 | 1341 | 0.090 |
Why?
|
| Stents | 2 | 2015 | 3257 | 0.090 |
Why?
|
| Reoperation | 9 | 2022 | 4192 | 0.090 |
Why?
|
| Heart Arrest | 2 | 2019 | 1458 | 0.090 |
Why?
|
| Heart Transplantation | 2 | 2020 | 3108 | 0.090 |
Why?
|
| Boston | 3 | 2017 | 9314 | 0.090 |
Why?
|
| Thymus Gland | 1 | 1995 | 1264 | 0.090 |
Why?
|
| Catheter Ablation | 1 | 2023 | 2737 | 0.090 |
Why?
|
| Fetal Death | 1 | 2012 | 446 | 0.090 |
Why?
|
| Italy | 2 | 2009 | 827 | 0.090 |
Why?
|
| Societies, Medical | 4 | 2021 | 3738 | 0.090 |
Why?
|
| Heart Diseases | 5 | 2000 | 2781 | 0.090 |
Why?
|
| Brachiocephalic Trunk | 1 | 2009 | 44 | 0.090 |
Why?
|
| Sheep | 2 | 2023 | 1434 | 0.090 |
Why?
|
| Heart Murmurs | 2 | 2007 | 94 | 0.090 |
Why?
|
| Endocardial Cushion Defects | 2 | 2006 | 45 | 0.090 |
Why?
|
| Aortography | 2 | 2021 | 429 | 0.090 |
Why?
|
| Phenotype | 6 | 2021 | 16300 | 0.090 |
Why?
|
| Intraoperative Complications | 2 | 1995 | 1184 | 0.080 |
Why?
|
| Congenital Abnormalities | 2 | 2006 | 708 | 0.080 |
Why?
|
| Risk Factors | 16 | 2017 | 71972 | 0.080 |
Why?
|
| Ultrasonography, Doppler, Pulsed | 1 | 2008 | 19 | 0.080 |
Why?
|
| Cardiac Imaging Techniques | 2 | 2021 | 269 | 0.080 |
Why?
|
| Gestational Age | 6 | 2019 | 3485 | 0.080 |
Why?
|
| Fibrosis | 3 | 2023 | 2024 | 0.080 |
Why?
|
| Dilatation, Pathologic | 3 | 2023 | 516 | 0.080 |
Why?
|
| Diagnosis, Differential | 6 | 2016 | 12945 | 0.080 |
Why?
|
| Transplantation, Heterologous | 1 | 2017 | 2381 | 0.080 |
Why?
|
| Electrocardiography | 11 | 2012 | 6425 | 0.080 |
Why?
|
| Doxorubicin | 2 | 1995 | 2215 | 0.080 |
Why?
|
| Hospitals, Pediatric | 1 | 2017 | 1744 | 0.080 |
Why?
|
| Registries | 4 | 2021 | 8039 | 0.080 |
Why?
|
| Program Evaluation | 1 | 2016 | 2484 | 0.080 |
Why?
|
| Ventricular Septum | 1 | 2008 | 72 | 0.080 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2015 | 1183 | 0.080 |
Why?
|
| Carcinoma, Bronchogenic | 1 | 1987 | 87 | 0.080 |
Why?
|
| Prospective Studies | 20 | 2016 | 53036 | 0.080 |
Why?
|
| Coronary Aneurysm | 1 | 2010 | 237 | 0.080 |
Why?
|
| Williams Syndrome | 1 | 2009 | 187 | 0.080 |
Why?
|
| Case-Control Studies | 5 | 2018 | 21691 | 0.080 |
Why?
|
| Protons | 1 | 2013 | 1120 | 0.080 |
Why?
|
| Perfusion | 2 | 2022 | 1353 | 0.080 |
Why?
|
| Animals | 14 | 2023 | 168358 | 0.070 |
Why?
|
| Ultrasonography, Doppler, Color | 1 | 2008 | 232 | 0.070 |
Why?
|
| Exercise Tolerance | 2 | 2016 | 766 | 0.070 |
Why?
|
| gamma-Globulins | 1 | 1986 | 124 | 0.070 |
Why?
|
| Funnel Chest | 1 | 1987 | 71 | 0.070 |
Why?
|
| Diastole | 5 | 1998 | 791 | 0.070 |
Why?
|
| Pulmonary Valve Insufficiency | 1 | 2008 | 151 | 0.070 |
Why?
|
| Pulse | 3 | 1988 | 229 | 0.070 |
Why?
|
| Heart Septum | 5 | 1992 | 313 | 0.070 |
Why?
|
| American Hospital Association | 1 | 2005 | 27 | 0.070 |
Why?
|
| Aortic Aneurysm, Thoracic | 1 | 2012 | 678 | 0.070 |
Why?
|
| Exercise Test | 4 | 2006 | 2069 | 0.070 |
Why?
|
| Biomedical Research | 1 | 2021 | 3300 | 0.070 |
Why?
|
| Systole | 6 | 1996 | 956 | 0.070 |
Why?
|
| Twins, Conjoined | 1 | 1985 | 41 | 0.070 |
Why?
|
| Mitral Valve Prolapse | 1 | 1987 | 230 | 0.070 |
Why?
|
| Cattle | 3 | 2017 | 3913 | 0.070 |
Why?
|
| Evaluation Studies as Topic | 4 | 1993 | 1676 | 0.070 |
Why?
|
| Ultrasonography, Doppler, Transcranial | 1 | 2006 | 302 | 0.060 |
Why?
|
| Ultrasonography | 6 | 2014 | 5941 | 0.060 |
Why?
|
| Clinical Competence | 2 | 2016 | 4671 | 0.060 |
Why?
|
| Blood Pressure | 9 | 2004 | 8553 | 0.060 |
Why?
|
| Vascular Surgical Procedures | 3 | 2003 | 1471 | 0.060 |
Why?
|
| Cardiomegaly | 4 | 1996 | 620 | 0.060 |
Why?
|
| Platelet Aggregation | 1 | 2008 | 800 | 0.060 |
Why?
|
| Amlodipine | 1 | 2004 | 79 | 0.060 |
Why?
|
| DNA-Binding Proteins | 1 | 2022 | 9625 | 0.060 |
Why?
|
| Methoxamine | 1 | 1983 | 45 | 0.060 |
Why?
|
| Axillary Artery | 1 | 1984 | 49 | 0.060 |
Why?
|
| Hepatic Veins | 1 | 1984 | 112 | 0.060 |
Why?
|
| Endocarditis, Bacterial | 2 | 2007 | 453 | 0.060 |
Why?
|
| Cerebrovascular Circulation | 2 | 2022 | 2755 | 0.060 |
Why?
|
| Complement Inactivator Proteins | 1 | 2004 | 79 | 0.060 |
Why?
|
| Vena Cava, Inferior | 2 | 2006 | 432 | 0.060 |
Why?
|
| Respiratory Function Tests | 2 | 2006 | 1611 | 0.060 |
Why?
|
| Calcium | 3 | 2015 | 5739 | 0.060 |
Why?
|
| Survival Analysis | 6 | 2006 | 10248 | 0.060 |
Why?
|
| Dobutamine | 1 | 1983 | 123 | 0.060 |
Why?
|
| Thrombosis | 1 | 2017 | 2962 | 0.060 |
Why?
|
| Immunoglobulins, Intravenous | 2 | 2000 | 646 | 0.060 |
Why?
|
| United States | 11 | 2012 | 69568 | 0.060 |
Why?
|
| Vascular Patency | 1 | 2006 | 888 | 0.060 |
Why?
|
| African Americans | 1 | 2002 | 23 | 0.060 |
Why?
|
| Syndrome | 5 | 2006 | 3241 | 0.060 |
Why?
|
| Quality Improvement | 1 | 2018 | 3730 | 0.060 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 | 1995 | 1513 | 0.060 |
Why?
|
| Catecholamines | 1 | 1983 | 387 | 0.050 |
Why?
|
| Hypertrophy | 2 | 2016 | 565 | 0.050 |
Why?
|
| Lung | 2 | 2022 | 9778 | 0.050 |
Why?
|
| Databases, Factual | 1 | 2017 | 7689 | 0.050 |
Why?
|
| Sensitivity and Specificity | 5 | 2008 | 14721 | 0.050 |
Why?
|
| Microcomputers | 1 | 2002 | 149 | 0.050 |
Why?
|
| Ticlopidine | 1 | 2008 | 899 | 0.050 |
Why?
|
| Blood Circulation | 1 | 1983 | 253 | 0.050 |
Why?
|
| Electric Conductivity | 1 | 2002 | 411 | 0.050 |
Why?
|
| Glycerol | 1 | 2023 | 277 | 0.050 |
Why?
|
| Acute Disease | 3 | 2001 | 7127 | 0.050 |
Why?
|
| Recovery of Function | 2 | 2016 | 2924 | 0.050 |
Why?
|
| Calcium Channel Blockers | 1 | 2004 | 686 | 0.050 |
Why?
|
| Death, Sudden, Cardiac | 2 | 2023 | 1542 | 0.050 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2006 | 588 | 0.050 |
Why?
|
| Videotape Recording | 1 | 2002 | 350 | 0.050 |
Why?
|
| Hospital Costs | 2 | 1997 | 982 | 0.050 |
Why?
|
| Troponin | 1 | 2004 | 516 | 0.050 |
Why?
|
| Heart Auscultation | 1 | 2000 | 37 | 0.050 |
Why?
|
| Computer Communication Networks | 1 | 2002 | 295 | 0.050 |
Why?
|
| Constriction, Pathologic | 2 | 2022 | 1095 | 0.040 |
Why?
|
| HIV Infections | 4 | 2000 | 16763 | 0.040 |
Why?
|
| Education, Medical | 2 | 2016 | 1712 | 0.040 |
Why?
|
| Remote Consultation | 1 | 2002 | 239 | 0.040 |
Why?
|
| Blood Pressure Determination | 1 | 1983 | 630 | 0.040 |
Why?
|
| Metaplasia | 1 | 2020 | 313 | 0.040 |
Why?
|
| Endocardium | 1 | 2000 | 261 | 0.040 |
Why?
|
| Ductus Arteriosus | 1 | 2019 | 39 | 0.040 |
Why?
|
| Vena Cava, Superior | 2 | 1994 | 193 | 0.040 |
Why?
|
| Hypertrophy, Left Ventricular | 2 | 2014 | 851 | 0.040 |
Why?
|
| Heart Function Tests | 3 | 2000 | 331 | 0.040 |
Why?
|
| Postoperative Period | 5 | 1993 | 1835 | 0.040 |
Why?
|
| Cohort Studies | 4 | 2018 | 40385 | 0.040 |
Why?
|
| Subclavian Artery | 1 | 2019 | 129 | 0.040 |
Why?
|
| Protective Agents | 1 | 2000 | 156 | 0.040 |
Why?
|
| Marfan Syndrome | 2 | 1990 | 239 | 0.040 |
Why?
|
| Stress, Mechanical | 4 | 1994 | 1682 | 0.040 |
Why?
|
| Fetus | 2 | 2022 | 1877 | 0.040 |
Why?
|
| Bacteremia | 1 | 2004 | 958 | 0.040 |
Why?
|
| Exercise Therapy | 1 | 2005 | 897 | 0.040 |
Why?
|
| Equipment and Supplies | 1 | 2000 | 280 | 0.040 |
Why?
|
| Preoperative Care | 5 | 1993 | 2237 | 0.040 |
Why?
|
| Thoracoscopy | 2 | 1995 | 178 | 0.040 |
Why?
|
| Postnatal Care | 1 | 2019 | 233 | 0.040 |
Why?
|
| Glutaral | 1 | 2017 | 78 | 0.040 |
Why?
|
| Hypertension | 3 | 2004 | 8430 | 0.040 |
Why?
|
| Embolism, Air | 2 | 1987 | 110 | 0.040 |
Why?
|
| Adipogenesis | 1 | 2019 | 356 | 0.040 |
Why?
|
| Adenoma | 1 | 1987 | 2163 | 0.040 |
Why?
|
| Catheterization, Peripheral | 1 | 2000 | 344 | 0.040 |
Why?
|
| Middle Aged | 14 | 2017 | 212833 | 0.030 |
Why?
|
| Coronary Circulation | 4 | 2007 | 1572 | 0.030 |
Why?
|
| Aftercare | 1 | 2022 | 858 | 0.030 |
Why?
|
| Chronic Disease | 2 | 2001 | 9132 | 0.030 |
Why?
|
| Research Design | 2 | 2002 | 5959 | 0.030 |
Why?
|
| Angiocardiography | 3 | 1994 | 162 | 0.030 |
Why?
|
| Ethics, Medical | 1 | 2001 | 793 | 0.030 |
Why?
|
| Femoral Artery | 1 | 2000 | 841 | 0.030 |
Why?
|
| Cadaver | 1 | 2020 | 1330 | 0.030 |
Why?
|
| Staphylococcal Infections | 1 | 2004 | 1402 | 0.030 |
Why?
|
| World Health Organization | 1 | 2021 | 1321 | 0.030 |
Why?
|
| Cardiology Service, Hospital | 1 | 1997 | 246 | 0.030 |
Why?
|
| Ventricular Remodeling | 2 | 2013 | 1222 | 0.030 |
Why?
|
| Acquired Immunodeficiency Syndrome | 4 | 1994 | 2241 | 0.030 |
Why?
|
| Pregnancy Trimester, Second | 4 | 2005 | 732 | 0.030 |
Why?
|
| Cardiomyopathy, Dilated | 2 | 1994 | 852 | 0.030 |
Why?
|
| Aging | 2 | 2000 | 8607 | 0.030 |
Why?
|
| Disease Progression | 3 | 2012 | 13237 | 0.030 |
Why?
|
| Collagen | 1 | 2023 | 2669 | 0.030 |
Why?
|
| Biocompatible Materials | 1 | 2023 | 1730 | 0.030 |
Why?
|
| False Negative Reactions | 4 | 1988 | 589 | 0.030 |
Why?
|
| Iopamidol | 1 | 2014 | 191 | 0.030 |
Why?
|
| North Carolina | 3 | 2002 | 310 | 0.030 |
Why?
|
| Cineangiography | 1 | 1993 | 124 | 0.030 |
Why?
|
| Prevalence | 3 | 2009 | 15152 | 0.030 |
Why?
|
| Reproducibility of Results | 7 | 2010 | 19787 | 0.030 |
Why?
|
| Pulmonary Subvalvular Stenosis | 1 | 1993 | 8 | 0.030 |
Why?
|
| Fluoroscopy | 2 | 2015 | 915 | 0.030 |
Why?
|
| Recurrence | 3 | 2015 | 8306 | 0.030 |
Why?
|
| Maternal Exposure | 1 | 2000 | 952 | 0.030 |
Why?
|
| HIV Antibodies | 1 | 2000 | 1309 | 0.030 |
Why?
|
| Odds Ratio | 2 | 2004 | 9846 | 0.030 |
Why?
|
| Comorbidity | 2 | 2007 | 10362 | 0.030 |
Why?
|
| Electrons | 1 | 2014 | 269 | 0.030 |
Why?
|
| HIV | 1 | 2000 | 1607 | 0.030 |
Why?
|
| Antihypertensive Agents | 1 | 2002 | 2039 | 0.030 |
Why?
|
| Posture | 2 | 1987 | 966 | 0.030 |
Why?
|
| Thermodynamics | 1 | 2014 | 594 | 0.030 |
Why?
|
| Multivariate Analysis | 3 | 2002 | 12235 | 0.030 |
Why?
|
| Linear Models | 1 | 2002 | 5946 | 0.030 |
Why?
|
| Analysis of Variance | 4 | 1996 | 6364 | 0.030 |
Why?
|
| Survival Rate | 3 | 2017 | 12760 | 0.030 |
Why?
|
| Immunoglobulins | 1 | 1995 | 881 | 0.030 |
Why?
|
| Iatrogenic Disease | 1 | 2015 | 544 | 0.030 |
Why?
|
| Renal Artery | 1 | 1993 | 398 | 0.020 |
Why?
|
| Models, Cardiovascular | 1 | 1996 | 994 | 0.020 |
Why?
|
| False Positive Reactions | 3 | 1988 | 981 | 0.020 |
Why?
|
| Severity of Illness Index | 4 | 2013 | 15510 | 0.020 |
Why?
|
| Zidovudine | 1 | 1992 | 623 | 0.020 |
Why?
|
| Pregnancy Outcome | 1 | 2000 | 2789 | 0.020 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 1994 | 688 | 0.020 |
Why?
|
| Postpartum Period | 1 | 1996 | 1070 | 0.020 |
Why?
|
| Blood Vessel Prosthesis | 1 | 1995 | 932 | 0.020 |
Why?
|
| Xiphoid Bone | 2 | 1986 | 10 | 0.020 |
Why?
|
| Patient Discharge | 1 | 2022 | 3286 | 0.020 |
Why?
|
| Lung Diseases | 1 | 2000 | 1878 | 0.020 |
Why?
|
| Arterio-Arterial Fistula | 1 | 1989 | 19 | 0.020 |
Why?
|
| Mutation | 3 | 2020 | 29659 | 0.020 |
Why?
|
| Oxygen | 3 | 2007 | 4163 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2019 | 2908 | 0.020 |
Why?
|
| Aged | 7 | 2015 | 162667 | 0.020 |
Why?
|
| Medical Records | 2 | 2007 | 1413 | 0.020 |
Why?
|
| Phonocardiography | 2 | 1987 | 34 | 0.020 |
Why?
|
| Reference Values | 2 | 1993 | 4981 | 0.020 |
Why?
|
| Electrocardiography, Ambulatory | 1 | 1991 | 584 | 0.020 |
Why?
|
| Angiography | 1 | 1993 | 1634 | 0.020 |
Why?
|
| Ellis-Van Creveld Syndrome | 1 | 2007 | 7 | 0.020 |
Why?
|
| Video Recording | 3 | 2000 | 936 | 0.020 |
Why?
|
| Angioplasty, Balloon, Coronary | 1 | 2015 | 1874 | 0.020 |
Why?
|
| Statistics, Nonparametric | 2 | 2004 | 2881 | 0.020 |
Why?
|
| Inflammation | 2 | 2019 | 10531 | 0.020 |
Why?
|
| Immunization, Passive | 1 | 1989 | 625 | 0.020 |
Why?
|
| Incidence | 4 | 2017 | 20912 | 0.020 |
Why?
|
| Morbidity | 1 | 2012 | 1763 | 0.020 |
Why?
|
| Radiography | 3 | 2007 | 6997 | 0.020 |
Why?
|
| Rats | 1 | 2023 | 24259 | 0.020 |
Why?
|
| Genetic Testing | 1 | 2019 | 3441 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 2 | 2001 | 7274 | 0.020 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2012 | 1440 | 0.020 |
Why?
|
| Random Allocation | 2 | 1989 | 2417 | 0.020 |
Why?
|
| Hospitals, University | 2 | 1997 | 567 | 0.020 |
Why?
|
| Health Services Accessibility | 1 | 2002 | 5128 | 0.020 |
Why?
|
| Heart Arrest, Induced | 1 | 2006 | 355 | 0.020 |
Why?
|
| Postoperative Care | 1 | 1991 | 1477 | 0.020 |
Why?
|
| Cell Line | 1 | 2019 | 15982 | 0.020 |
Why?
|
| Rheology | 1 | 1986 | 345 | 0.020 |
Why?
|
| Procainamide | 1 | 1984 | 61 | 0.020 |
Why?
|
| Tropomyosin | 1 | 2004 | 102 | 0.020 |
Why?
|
| Sports Medicine | 1 | 1987 | 225 | 0.020 |
Why?
|
| Injections, Intravenous | 1 | 1986 | 1420 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2017 | 11348 | 0.010 |
Why?
|
| Placenta | 1 | 2013 | 1682 | 0.010 |
Why?
|
| Thorax | 1 | 2007 | 545 | 0.010 |
Why?
|
| Methods | 3 | 1989 | 1132 | 0.010 |
Why?
|
| Respiration Disorders | 1 | 2007 | 369 | 0.010 |
Why?
|
| Curriculum | 1 | 2016 | 3575 | 0.010 |
Why?
|
| MicroRNAs | 1 | 2019 | 3710 | 0.010 |
Why?
|
| Veins | 1 | 1987 | 767 | 0.010 |
Why?
|
| Craniotomy | 1 | 1987 | 728 | 0.010 |
Why?
|
| Apoptosis | 1 | 2019 | 9708 | 0.010 |
Why?
|
| Aneurysm | 1 | 1986 | 339 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 1987 | 12983 | 0.010 |
Why?
|
| Catheterization | 1 | 1988 | 1466 | 0.010 |
Why?
|
| Papillary Muscles | 1 | 1983 | 198 | 0.010 |
Why?
|
| Physical Exertion | 1 | 1985 | 695 | 0.010 |
Why?
|
| Computer Peripherals | 1 | 2002 | 38 | 0.010 |
Why?
|
| Skull | 1 | 1986 | 809 | 0.010 |
Why?
|
| Regression Analysis | 1 | 1992 | 6451 | 0.010 |
Why?
|
| Bronchi | 1 | 1986 | 838 | 0.010 |
Why?
|
| Tachycardia | 1 | 1984 | 621 | 0.010 |
Why?
|
| Risk | 1 | 2014 | 9684 | 0.010 |
Why?
|
| Hypothermia, Induced | 1 | 2006 | 746 | 0.010 |
Why?
|
| Contrast Media | 1 | 2014 | 5287 | 0.010 |
Why?
|
| Chromosome Deletion | 1 | 2006 | 1401 | 0.010 |
Why?
|
| 1-Carboxyglutamic Acid | 1 | 1980 | 20 | 0.010 |
Why?
|
| Legislation, Drug | 1 | 2002 | 206 | 0.010 |
Why?
|
| Baltimore | 1 | 2001 | 230 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2019 | 18002 | 0.010 |
Why?
|
| Diagnostic Errors | 1 | 1987 | 1253 | 0.010 |
Why?
|
| Capillary Permeability | 1 | 2004 | 799 | 0.010 |
Why?
|
| Logistic Models | 2 | 1995 | 13400 | 0.010 |
Why?
|
| Trachea | 1 | 1986 | 1074 | 0.010 |
Why?
|
| Internship and Residency | 1 | 2000 | 5761 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2019 | 12134 | 0.010 |
Why?
|
| Clinical Trials, Phase II as Topic | 1 | 2002 | 618 | 0.010 |
Why?
|
| Sports | 1 | 1985 | 685 | 0.010 |
Why?
|
| Renal Dialysis | 1 | 1987 | 1780 | 0.010 |
Why?
|
| Down Syndrome | 2 | 1997 | 873 | 0.010 |
Why?
|
| Regional Blood Flow | 2 | 1995 | 1528 | 0.010 |
Why?
|
| Probability | 1 | 2003 | 2500 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2014 | 8919 | 0.010 |
Why?
|
| Vascular Resistance | 1 | 1980 | 942 | 0.010 |
Why?
|
| Staphylococcus aureus | 1 | 2004 | 1448 | 0.010 |
Why?
|
| Cost Savings | 1 | 2002 | 925 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2004 | 4935 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 1986 | 6478 | 0.010 |
Why?
|
| Bone and Bones | 1 | 2007 | 2574 | 0.010 |
Why?
|
| Hemorrhage | 1 | 2008 | 3440 | 0.010 |
Why?
|
| Weight Lifting | 2 | 1987 | 131 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2008 | 10939 | 0.010 |
Why?
|
| Swimming | 2 | 1987 | 205 | 0.010 |
Why?
|
| Constriction | 1 | 1995 | 181 | 0.010 |
Why?
|
| Ventricular Function | 2 | 1987 | 416 | 0.010 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2008 | 3066 | 0.010 |
Why?
|
| Kidney Failure, Chronic | 1 | 1987 | 2546 | 0.010 |
Why?
|
| Administration, Oral | 1 | 2002 | 3909 | 0.010 |
Why?
|
| Sex Factors | 2 | 2000 | 10397 | 0.010 |
Why?
|
| Equipment Safety | 1 | 1995 | 264 | 0.010 |
Why?
|
| Pregnancy Trimester, Third | 1 | 1996 | 568 | 0.010 |
Why?
|
| Observer Variation | 1 | 2000 | 2587 | 0.010 |
Why?
|
| Ligation | 1 | 1994 | 452 | 0.010 |
Why?
|
| Levocardia | 1 | 1993 | 2 | 0.010 |
Why?
|
| Transducers | 1 | 1994 | 252 | 0.010 |
Why?
|
| Intensive Care Units | 1 | 1986 | 3672 | 0.010 |
Why?
|
| HIV-1 | 1 | 1990 | 6930 | 0.010 |
Why?
|
| Kidney Transplantation | 1 | 1987 | 4220 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2004 | 13815 | 0.010 |
Why?
|
| Creatine Kinase | 1 | 1994 | 694 | 0.010 |
Why?
|
| Pregnancy Trimester, First | 1 | 1996 | 848 | 0.010 |
Why?
|
| Blood Volume | 1 | 1993 | 565 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2004 | 9738 | 0.010 |
Why?
|
| Protein Conformation | 1 | 2000 | 4013 | 0.010 |
Why?
|
| Atrophy | 1 | 1996 | 1569 | 0.010 |
Why?
|
| Coronary Disease | 1 | 1986 | 6067 | 0.010 |
Why?
|
| Gene Expression | 1 | 2004 | 7789 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2004 | 18124 | 0.010 |
Why?
|
| Costs and Cost Analysis | 1 | 1997 | 1675 | 0.010 |
Why?
|
| Patient Care Team | 1 | 2002 | 2527 | 0.010 |
Why?
|
| Monitoring, Physiologic | 2 | 1989 | 1735 | 0.010 |
Why?
|
| Motion | 1 | 1994 | 795 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2004 | 11985 | 0.010 |
Why?
|
| Osteosarcoma | 1 | 1995 | 884 | 0.010 |
Why?
|
| Autoradiography | 1 | 1990 | 764 | 0.010 |
Why?
|
| Risk Assessment | 2 | 2003 | 23292 | 0.010 |
Why?
|
| Spleen | 1 | 1995 | 2358 | 0.010 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1990 | 1373 | 0.010 |
Why?
|
| Socioeconomic Factors | 1 | 2002 | 7726 | 0.010 |
Why?
|
| Age of Onset | 1 | 1995 | 3263 | 0.010 |
Why?
|
| Mortality | 1 | 1980 | 2851 | 0.000 |
Why?
|
| Virus Diseases | 1 | 1994 | 710 | 0.000 |
Why?
|
| Myocarditis | 1 | 1994 | 760 | 0.000 |
Why?
|
| Thermodilution | 1 | 1986 | 51 | 0.000 |
Why?
|
| Mice, Inbred C57BL | 1 | 2004 | 21859 | 0.000 |
Why?
|
| Adaptation, Biological | 1 | 1987 | 151 | 0.000 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2002 | 9812 | 0.000 |
Why?
|
| Anesthesia, Inhalation | 1 | 1986 | 223 | 0.000 |
Why?
|
| Chromosome Aberrations | 1 | 1992 | 1811 | 0.000 |
Why?
|
| Pediatric Nursing | 1 | 1986 | 103 | 0.000 |
Why?
|
| Pressure | 1 | 1988 | 1202 | 0.000 |
Why?
|
| Survivors | 1 | 1995 | 2280 | 0.000 |
Why?
|
| Cardiac Pacing, Artificial | 1 | 1988 | 846 | 0.000 |
Why?
|
| Carotid Arteries | 1 | 1988 | 952 | 0.000 |
Why?
|
| Length of Stay | 1 | 1997 | 6294 | 0.000 |
Why?
|
| Computers | 1 | 1986 | 614 | 0.000 |
Why?
|
| DNA, Viral | 1 | 1990 | 2225 | 0.000 |
Why?
|
| Craniosynostoses | 1 | 1987 | 398 | 0.000 |
Why?
|
| Running | 1 | 1987 | 476 | 0.000 |
Why?
|
| RNA, Viral | 1 | 1990 | 2907 | 0.000 |
Why?
|
| Cause of Death | 1 | 1991 | 3564 | 0.000 |
Why?
|
| Longitudinal Studies | 1 | 1995 | 13880 | 0.000 |
Why?
|
| Hospital Mortality | 1 | 1993 | 5305 | 0.000 |
Why?
|
| Proportional Hazards Models | 1 | 1993 | 12328 | 0.000 |
Why?
|
| Aged, 80 and over | 2 | 1994 | 57639 | 0.000 |
Why?
|
| Mice | 1 | 2004 | 80995 | 0.000 |
Why?
|
| Exercise | 1 | 1993 | 5590 | 0.000 |
Why?
|
| Cross-Sectional Studies | 1 | 1992 | 24711 | 0.000 |
Why?
|
| Neoplasms | 1 | 1994 | 21499 | 0.000 |
Why?
|